Experts shocked about HIV patients reluctance to undergo treatment
588  

Experts shocked about HIV patients reluctance to undergo treatment

The number of HIV patients that underwent treatment in Q1 2018 did not change in Latvia even though a considerable amount of funding was allocated from the state budget for HIV/AIDS treatment in 2018. This creates concerns about HIV patients’ use of healthcare services, according ...

May 07, 2018
News  
Treatment of HIV patients in Latvia will start earlier since this year
1134  

Treatment of HIV patients in Latvia will start earlier since this year

The beginning of 2018 brings forth positive changes in the treatment of HIV-positive patients: additional budget funding will allow to increase the CD4 immune cells level at which the patients are eligible to start a governmentally-funded therapy, which is now 500 cells/mcl. Until this time, ...

January 10, 2018
News  
Long-term data do not support Raltegravir as second-line HIV therapy
790  

Long-term data do not support Raltegravir as second-line HIV therapy

A second-line HIV regimen containing the integrase inhibitor raltegravir failed to meet its primary endpoint of noninferiority against standard second-line treatment with nucleoside reverse-transcriptase inhibitors, or NRTIs, according to 144-week data from the EARNEST trial.

November 20, 2017
News  
ART price reduction to be ensured in Kyrgyzstan
847  

ART price reduction to be ensured in Kyrgyzstan

More than 100 experts in the HIV/AIDS response area from all over the country convened at a round table in Bishkek (Kyrgyz Republic) on November 13 to discuss the issues of increasing access to medicines and ensuring the transparent functioning of medical institutions. The meeting ...

November 14, 2017
ECUO  News